Skip to content

Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Phase III, randomized, placebo-controlled, double-blind, crossover study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517706-29-00
Acronym
IB1001-303
Enrollment
45
Registered
2025-03-25
Start date
2025-05-13
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ataxia Telangiectasia

Brief summary

The primary endpoint for the study is of the Scale for the Assessment and Rating of Ataxia

Detailed description

Spinocerebellar Ataxia Functional Index (SCAFI) is one of the four secondary endpoints., International Cooperative Rating Scale (ICARS) is one of the four secondary endpoints., Quality of Life EQ-5D-5L for patients aged ≥18; EQ-5D-Y for patients aged <18 years is one of the four secondary endpoints., Investigator’s, Caregiver’s (if applicable), and Patient’s (if able) Clinical Global Impression of Improvement (CGI-I) comparing end of period I (Visit 4) to baseline (Visit 2) is one of the four secondary endpoints.

Interventions

Sponsors

Intrabio Limited
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
0 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The primary endpoint for the study is of the Scale for the Assessment and Rating of Ataxia

Secondary

MeasureTime frame
Spinocerebellar Ataxia Functional Index (SCAFI) is one of the four secondary endpoints., International Cooperative Rating Scale (ICARS) is one of the four secondary endpoints., Quality of Life EQ-5D-5L for patients aged ≥18; EQ-5D-Y for patients aged <18 years is one of the four secondary endpoints., Investigator’s, Caregiver’s (if applicable), and Patient’s (if able) Clinical Global Impression of Improvement (CGI-I) comparing end of period I (Visit 4) to baseline (Visit 2) is one of the four secondary endpoints.

Countries

Germany, Slovakia, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026